Based on the finding that FGF2 and ACLY collaboratively mediated the carcinogenic effect of ONECUT2, we investigated the efficacy of a combined intervention targeting FGF2 and ACLY against ONECUT2-mediated HCC metastasis. Here, ACLY is linked to hepatocellular carcinoma.